PMID: 6103385May 10, 1980Paper

Heterotopic liver transplantation in end-stage HBsAg-positive cirrhosis

Lancet
D HoussinH Bismuth

Abstract

A patient with end-stage cirrhosis complicating HBsAg-positive chronic active hepatitis given a heterotopic liver transplant is alive and well 28 months after transplantation; liver function is normal, and there are no hepatitis-B related lesions on the liver graft despite positivity of HBsAg in the serum. This observation confirms that a heterotopic liver graft can offer long-term survival in man and suggests that this technique may be a more suitable procedure than orthotopic transplantation in end-stage cirrhotics.

References

Mar 1, 1977·World Journal of Surgery·C W PutnamT E Starzl
Jan 1, 1978·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·F HessC Jerusalem
Jan 1, 1976·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·F HessM Polak
Jan 1, 1972·Archives of Surgery·F HessM N van der Heyde
Jan 1, 1984·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·M MinatoH Bismuth

❮ Previous
Next ❯

Citations

Mar 1, 1992·Transplant International : Official Journal of the European Society for Organ Transplantation·J D BlankensteijnO T Terpstra
Apr 1, 1988·Transplant International : Official Journal of the European Society for Organ Transplantation·B RingeM Burdelski
Jan 1, 1983·European Journal of Nuclear Medicine·M W de JongeJ L Terpstra
Jul 1, 1983·World Journal of Surgery·H BismuthG Mazmanian
Jul 1, 1985·The Japanese Journal of Surgery·S InoueY Morioka
Jan 1, 1987·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·X P Chen
Sep 25, 2002·Transplantation Proceedings·N D Heaton, D Maguire
Nov 1, 1985·Seminars in Liver Disease·S TodoT E Starzl
Jan 1, 1995·Transplant International : Official Journal of the European Society for Organ Transplantation·M RelaK C Tan
Jul 11, 1981·British Medical Journal
Dec 1, 1988·Transplant International : Official Journal of the European Society for Organ Transplantation·D HoussinN Pras-Jude
Jul 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A A Shaked, R W Busuttil
Jan 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P J WillemseS W Schalm
Oct 19, 1989·The New England Journal of Medicine·T E StarzlD Van Thiel
Sep 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T E StarzlK A Porter
Apr 1, 1990·Current Problems in Surgery·T E Starzl, A J Demetris
Oct 8, 2021·Annals of Surgery·Henri Bismuth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.